He was first diagnosed with chronic lymphocytic leukaemia (CLL) when he was just 36 years old ... In the wake of the news, he ...

Advances in drug discovery, coupled with regulatory approvals for novel drugs like inotuzumab for acute lymphoblastic leukemia, underscore the industry’s commitment to addressing unmet clinical needs.

Mike Peters of The Alarm has appealed to people to become potential stem cell donors. Peters, who was forced to cancel a US ...

At the age of 30, Nicholas Filtz was diagnosed with a rare form of cancer, and on this Veterans Day, he is sharing his cancer ...

Mike Peters, frontman of Welsh band The Alarm, has said his “future is uncertain” as he implored people to become potential ...

The Prestatyn-born rock star was given the all-clear earlier this year - but his rare and aggressive lymphoma returned last ...

That was among the many special moments for 11-year-old Cooper Trueblood at the Washington Capitals’ annual Hockey Fights ...

The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

On November 8, the US Food and Drug Administration approved Aucatzyl (obecabtagene autoleucel; obe-cel) from US biopharma Autolus Therapeutics, whose share rose more than 8% to 44.03 on the news.